# Hypoglycemia Management â€“ Clinical Call Protocol

**Guideline References:**  
- American Diabetes Association (ADA) Standards of Care 2024: https://diabetes.org/standards  
- Endocrine Society Clinical Practice Guideline (2022): https://www.endocrine.org  
- Joint British Diabetes Societies Inpatient Guidance (JBDS-IP) 2022: https://abcd.care/resource/joint-british-diabetes-societies
- UpToDate: "Management of hypoglycemia in adults with diabetes" (accessed July 2025): https://www.uptodate.com/contents/management-of-hypoglycemia-in-adults-with-diabetes

---

## CARD INTERFACE LAYOUT

---

### Card 0 â€” Dynamic Action Card (Node Dependent)

#### Initial Call/Immediate Actions (Dynamic)
~~~text
â€¢ POC Glucose: **42** mg/dL âš ï¸

â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚        IMMEDIATE HYPOGLYCEMIA ACTIONS       â”‚
â”‚                                             â”‚
â”‚ â˜‘ Confirm with lab glucose                   â”‚
â”‚ â˜‘ D50 25mL IV push NOW                      â”‚
â”‚ â˜‘ Recheck glucose in 15 min                  â”‚
â”‚ â˜ If no IV: Glucagon 1mg IM or 3mg nasal     â”‚
â”‚ â˜ Repeat q15min until >70 mg/dL              â”‚
â”‚ â˜ Once alert, give oral carbs if safe        â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

RISK FACTORS:
â€¢ NPO for procedure tomorrow
â€¢ Glargine 40 units last dose (long-acting)
â€¢ CKD Stage 3 (â†“ insulin clearance)
â€¢ No dinner eaten

â° HIGH risk for recurrent hypoglycemia
**Due to long-acting insulin + reduced oral intake**.
~~~

#### Recurrence Risk/Prevention Node (Dynamic)
~~~text
HYPOGLYCEMIA RECURRENCE RISK
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€

Risk Factors Present:
â˜‘ Long-acting insulin (glargine, detemir, degludec)
â˜‘ NPO status
â˜‘ Renal/hepatic impairment
â˜‘ Elderly, cognitive impairment
â˜‘ Sulfonylureas or CKD (if present)
â˜‘ Missed dinner/poor intake

Protocol Actions:
â€¢ Initiate D10W infusion if recurrent/unstable
â€¢ Hold or reduce insulin/sulfonylurea (per ADA 2024, JBDS-IP 2022)
â€¢ Increase frequency of monitoring (q1h Ã— 4, then q2-4h)
â€¢ Early endocrine consult for persistent hypoglycemia
â€¢ Document events + treatment/alert team
~~~

---

### Card 1 â€” Clinical Assessment (Static)
~~~text
HYPOGLYCEMIA CLASSIFICATION & PRESENTATION

Levels:
Level 1 ("Alert"):
â€¢ 54â€“69 mg/dL; self-treat possible; oral glucose preferred

Level 2 ("Serious"):
â€¢ <54 mg/dL; may need assistance/cognitive impairment

Level 3 ("Severe"):
â€¢ Altered mental status, seizure/coma, external help required

Clinical Signs:
Autonomic: diaphoresis, tremor, palpitations, anxiety, hunger, nausea
Neuroglycopenic: confusion, seizures, LOC, visual changes, focal deficits

Common Etiologies:
Medication (insulin, sulfonylurea), dietary intake (missed meals/fasting), chronic kidney/liver disease, exercise, drug interactions (beta-blockers, alcohol), adrenal insufficiency, severe sepsis

Hospital Risks:
â€¢ NPO/surgical procedure
â€¢ Poor mealâ€“med timing
â€¢ Steroid tapers
â€¢ Unrecognized CKD/elderly/frail/hypoglycemia unawareness
~~~

---

### Card 2 â€” Treatment Protocols (Static)
~~~text
HYPOGLYCEMIA TREATMENT â€” ADA/JBDS-IP 2024

ğŸ¬ CONSCIOUS (swallowing intact, alert):
â€¢ 15g rapid-acting carbohydrate (juice/glucose tabs/soda/honey)
â€¢ Recheck in 15 min; repeat if glucose <70mg/dL
â€¢ Once >70 & eating: give snack with complex carb + protein

ğŸ’‰ Altered (confused/unresponsive/NPO):
â€¢ D50 25 mL IV push NOW (12.5g dextrose) â€” repeat q15min if <70 mg/dL
â€¢ D10W 100â€“150 mL IV as alternative to D50 for small veins
â€¢ If no IV: glucagon 1mg IM/SC or 3mg intranasal (if available; not effective with no hepatic glycogen)

ğŸ” For persistent/recurrent episodes:
â€¢ Start D10 infusion @ 50â€“100 mL/hr (provides 5â€“10g/hr glucose)
â€¢ Check glucose q1h, titrate rate to keep 100â€“150mg/dL

ğŸ” Recurrent/unexplained: order
â€¢ C-peptide, insulin, concurrent meds, cortisol, LFTs
â€¢ Consider sulfonylurea screen, Whippleâ€™s triad assessment

âš ï¸ Special Populations:
â€¢ Sulfonylurea toxicity (glyburide, glipizide, glimepiride): admit/observe, consider octreotide 50â€“100 mcg SC q8h
â€¢ CKD/liver disease: reduced gluconeogenesis/prolonged hypoglycemia, may need higher dextrose dose
â€¢ Thiamine before glucose in malnourished/alcoholic/encephalopathic

PREVENTION:
â€¢ Reduce/hold insulin for NPO or low output
â€¢ Temporarily suspend sulfonylureas after hypoglycemia event
â€¢ Monitor frequently; adjust targets if elderly/frail
~~~

---

## ALGORITHM DECISION TREE

~~~mermaid
graph TD
    A[Glucose <70 mg/dL] --> B{Patient Alert?}
    B -->|Yes| C[15g Oral Carbs<br/>Rule of 15]
    B -->|No| D{IV Access?}
    C --> E[Recheck in 15 min]
    D -->|Yes| F[D50 25mL IV Push]
    D -->|No| G[Glucagon 1mg IM/3mg Nasal]
    E --> H{Glucose >70?}
    F --> I[Recheck q15min]
    G --> I
    H -->|Yes| J[Give Snack, Monitor q1h]
    H -->|No| K[Repeat 15g Carbs]
    I --> L{Glucose >70?}
    L -->|Yes| M[Assess for Recurrence Risk]
    L -->|No| N[Repeat D50, Consider D10 Infusion]
    K --> E
    N --> O[Start D10 @ 75mL/hr, Check q1h]
    M --> P{High Recurrence Risk?}
    P -->|Yes| Q[D5/10 Infusion, Frequent Monitoring]
    P -->|No| R[Resume Diet, Standard Monitor]
    J --> P
    O --> S[Investigate Underlying Cause, Adjust Meds]
    Q --> S
~~~

---

## NODE-TO-DYNAMIC CARD MAPPING & INTERACTIVE COMPONENTS

| **Algorithm Node**            | **Dynamic Card Prompt/Question**                                   | **Interface/Interactive Elements**                  |
|------------------------------ |-------------------------------------------------------------------|-----------------------------------------------------|
| Glucose <70 mg/dL             | "Is patient alert and able to swallow?"                            | [Alert? Y/N], [PO route ready?], [Call help button] |
| Rule of 15 (Oral)             | "Give 15g carbs, recheck in 15min. Did glucose correct?"           | [15g Sheet], [Recheck Timer], [Next Step]           |
| IV Access/Unconscious         | "Give D50 25ml IV push/frequency. No IV? Use Glucagon IM/nasal"    | [IV/No IV radio], [Glucagon/Repeat D50 buttons]     |
| Assess Recurrence Risk        | "Does this patient need preventive infusion/med adjustment?"       | [Risk factor checklist], [Infusion manager]         |
| Persistent/repeated episodes  | "Start D10W @ 75mL/h. How is glucose trending? Adjust as needed."  | [Infusion input], [Hourly glucose chart]            |
| Prevention/Education          | "Was this a preventable event? Adjust medication? Notify team?"    | [Educator pop-up], [Endocrine consult button]       |

---

## INTERACTIVE ELEMENTS

### Hypoglycemia Treatment Calculator

~~~text
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚    HYPOGLYCEMIA TREATMENT GUIDE         â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚ Glucose: 42 mg/dL                       â”‚
â”‚ Mental Status: Somnolent                â”‚
â”‚ IV Access: YES                          â”‚
â”‚                                         â”‚
â”‚ â†’ D50W 25mL IV push NOW                â”‚
â”‚ â†’ Recheck q15min x 2                    â”‚
â”‚ If no response or >3 episodes:          â”‚
â”‚ Start D10 at 75mL/hr & monitor          â”‚
â”‚ After recovery, give snack or titrate   â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
~~~

### Recurrence Risk Assessment

~~~text
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚   HYPOGLYCEMIA RECURRENCE RISK ASSESS   â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚ Factors:                                â”‚
â”‚ â˜‘ Long-acting insulin                   â”‚
â”‚ â˜‘ NPO status/procedure                  â”‚
â”‚ â˜‘ CKD/Liver disease                     â”‚
â”‚                                         â”‚
â”‚ HIGH RISK â†’ Start D10W infusion         â”‚
â”‚ Frequent monitoring, adjust meds        â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
~~~

### D10 Infusion Manager

~~~text
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚   D10W INFUSION MANAGEMENT             â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚ Current Rate: 75 mL/hr                 â”‚
â”‚ Titrate: q1h to maintain >70 mg/dL     â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
~~~

---

**Protocol last updated to reflect ADA/EASD/Endocrine Society/UK JBDS-IP 2022â€“2024 standards. All steps match the emergency management consensus for inpatient and critical care hypoglycemia. External links above allow clinical validation and full context for rapid-response reference.**
